Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment

Fig. 3

Least square mean improvements in on-treatment reliever use from baseline in patients treated with BUD/FORM MRT or fixed-dose BUD, stratified by baseline reliever use (<1, 1–2 and >2 occasions/day). The error bars represent 95% CI. Statistical comparisons are for BUD/FORM MRT compared with fixed-dose BUD. BUD budesonide, CI confidence intervals, FORM formoterol, MRT maintenance and reliever therapy. * –0.03 occasions/day (95% CI: −0.20, 0.13), p = 0.68; † −0.33 occasions/day (95% CI: −0.48, −0.18), p < 0.0001; ‡ −0.74 occasions/day (95% CI: −1.03, −0.45), p < 0.0001

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us